相关实验视频

Updated: Jan 12, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Published on: September 28, 2015

平滑肌肉LRRC8A淘汰赛在Ang II高血压中保护了血管功能

Hyehun Choi¹, Sourav Panja¹, Hong-Ngan Nguyen¹

¹Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.

Hypertension (Dallas, Tex. : 1979)

|November 4, 2025

概括

移除LRRC8A离子通道可以防止Ang II诱导的高血压和血管功能障碍. 淘汰赛小鼠显示血管功能得到保护,血压下降改善,这表明LRRC8AA.

科学领域:

心血管生物学心血管生物学
分子医学是分子医学.
血管生理学血管生理学

背景情况:

ангиотензин II (Ang II) 通过像TNFα这样的细胞因子诱导高血压和血管炎症.
在血管光滑肌细胞 (VSMCs) 中,Ang II和TNFα激活NADPH氧化酶1 (Nox1) 并与LRRC8A离子通道结合.
LRRC8A通道以RhoA依赖的方式调节炎症和收缩性,影响血管损伤.

研究的目的:

研究LRRC8A离子通道在Ang II诱导的高血压和血管功能障碍中的作用.
为了确定LRRC8A淘汰赛是否保留血管功能,并降低输入Ang II的小鼠的血压.

主要方法:

野生型和LRRC8A淘汰赛小鼠接受了为期14天的Ang II输液.
血压通过放射测距法进行监测.
使用线路肌谱评估大动脉和中枢动脉功能,并将VSMCs隔离用于分析.

主要成果:

LRRC8A淘汰赛小鼠在Ang II输液后不活跃期间表现出保存的血压下降.
淘汰赛小鼠的血管功能较少受损,保持了对乙胆的放松,并减少了对北上腺素和血清素的收缩.
淘汰船体表现出减少的增殖 (PCNA) 和由Ang II诱导的衰老,以及减少的Rho激酶活性标志物.

结论:

LRRC8A离子通道是Ang II诱导的高血压中VSMC炎症和血管功能障碍的关键调解者.
准LRRC8A可能提供一种治疗策略,以保持血管功能并改善高血压条件下的血压调节.

关键词:

ангиотензин II 的使用这种高血压,高血压.这是一种炎症炎症炎症炎症.中腔动脉是中腔动脉.这是一种超氧化物.

更多相关视频

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Published on: December 5, 2017

Assessing Murine Resistance Artery Function Using Pressure Myography

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

相关概念视频

Antihypertensive Drugs: Angiotensin II Receptor Blockers

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...